BOC Sciences Blog

Covalent and Non-Covalent BTK Inhibitors: Development and Applications

What Is the Potential of BTK Inhibitors?

B Cell Receptor (BCR) signaling pathway overview BCR is a transmembrane protein complex that controls B cell maturation, survival, apoptosis, and the production of plasma cell antibodies starting from the […]

Small Molecule Drugs for Cancer Immunotherapy

Progress and Promise: Small Molecule Drugs for Cancer Immunotherapy

Overview of cancer immunotherapy The most widely studied cancer immunotherapies are PD-1/PD-L1 immune checkpoint inhibitors and chimeric antigen receptor-T cell (CAR-T) therapy. With the expanded clinical applications, some defects of […]

Nucleoside Monomers

Breaking the Barrier: Chemical Modification of Nucleoside Monomers

Small nucleic acid-based drugs, namely oligonucleotide drugs, are short-chain nucleic acids consisting of dozens of nucleotides in series. At present, most oligonucleotide drugs are obtained through solid-phase chemical synthesis by […]

10 Small Molecule Drugs Approved for COVID-19

A Glance at 10 Small Molecule Drugs Approved for COVID-19

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a betacoronavirus and possesses a positive-sense single-stranded RNA genome that contains 14 open reading frames (ORFs). Two […]

Cancer

Immune Checkpoint Target: TIGIT

TIGIT is considered to be one of the most promising and potential targets, and a variety of evidence supports that TIGIT plays a key role in limiting the adaptive and […]

Fluorescent Labels

Introduction to Fluorescent Labels: Cyanine Dyes Cy7, Cy5, Cy5.5, and Cy3

BOC Sciences provides varieties of fluorescent-labeled products and services to assist research in related fields.

SARS

Mesothelin: A New Target for Cancer Therapy

Structure and function of mesothelin The MSLN gene is located in chromosome 16p13. It contains 17 exons, with a cDNA length of about 2138bp, has a 1884-bp open reading frame, […]

The Research Progress in SHP2 and the Inhibitors

BOC Sciences has directed sincere efforts toward the R&D of small-molecule inhibitors (inhibitors, agonists, and modulators), which greatly free researchers from material outsourcing and selection workload.

mRNA-vaccine

Common Nucleosides as Raw Materials for In Vitro Diagnosis

Messenger RNA (mRNA) was first discovered in the 1960s, but its instability and immunogenicity have severely hindered the development of mRNA therapy. To solve this problem, researchers have contrived several […]

Small Molecule Drugs for Cancer Immunotherapy

Click Chemistry and Its Applications in Medicinal Chemical Synthesis

Click chemistry has developed organic reaction methodologies that are rapid, effective, and specifically selective, and its reaction system is not sensitive to oxygen or water. This article first reviews the […]